Indication

Necrobiosis lipoidica diabeticorum

Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance. Read more about Necrobiosis lipoidica diabeticorum

8 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Necrobiosis lipoidica diabeticorum therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Necrobiosis lipoidica diabeticorum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Necrobiosis lipoidica diabeticorum.

Necrobiosis lipoidica diabeticorum is a rare, chronic granulomatous skin disease classically associated with diabetes mellitus, particularly affecting young-to-middle-aged adults and exhibiting a marked female predominance.

It typically presents on the pretibial surfaces of the lower extremities as well-demarcated, yellowish-brown plaques characterized by raised violaceous borders, central epidermal atrophy, and prominent overlying telangiectasias.

Pathophysiologically, the condition is driven by microangiopathic changes, granulomatous inflammation, collagen degeneration (necrobiosis), and lipid deposition within the dermis and subcutaneous tissue.

Due to marked tissue fragility, affected plaques frequently suffer painful ulcerations following minor trauma and can rarely undergo malignant transformation into squamous cell carcinoma.

Personalize your experience

Follow Necrobiosis lipoidica diabeticorum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it